CADL
CADL
US1374041093
Candel Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
760.59M EUR
784.02M EUR
358.96M EUR
310.18M EUR
Enterprise Value
587.12M EUR
631.97M EUR
213.4M EUR
239.48M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-15.9x
--
--
--
Price to Sales
--
--
--
--
Price to Book
6x
6.22x
2.6x
5.97x
EV/Revenue
--
--
--
--
EV/EBITDA
-8.23x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.7%
-7.31%
-13.65%
-9.76%
ende